Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer

Mostrar otras versiones (1)

BACKGROUND: Mutations of EGFR and K-ras are biomarkers for predicting the efficacy of targeting agents in non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC). Data on the gene mutation status of EGFR and K-ras in Chinese patients with CRC are limited. METHODS: EGFR mutations in exon 18-21...

Descripción completa

Detalles Bibliográficos
Autores principales: Yunxia, Zuo, Jun, Cao, Guanshan, Zhu, Yachao, Lu, Xueke, Zhou, Jin, Li
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848222/
https://www.ncbi.nlm.nih.gov/pubmed/20184776
http://dx.doi.org/10.1186/1471-2350-11-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848222/
https://www.ncbi.nlm.nih.gov/pubmed/20184776
http://dx.doi.org/10.1186/1471-2350-11-34

Ejemplares similares